FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

New Info Could Increase Doc DTC Support

[ Price : $8.95]

Physicians participating in Sermos online community say they could support DTC ads that better explained relative and individual r...

Merck Plans Vaccine Production Boost in New Facility

[ Price : $8.95]

Merck intends to expand a vaccine manufacturing production facility in Durham, NC to support its growing vaccine business.

Epix to Appeal to Galson Over Vasovist

[ Price : $8.95]

Epix Pharmaceuticals says it will appeal a finding last August that its blood-pool imaging agent Vasovist had not been shown safe ...

DTC Letters Have Limited Effectiveness: GAO

[ Price : $8.95]

The Government Accountability Office says FDAs inability to systematically determine which DTC ads to review and the length of tim...

Farm Antibiotics: Time for FDA to Think Outside the Box

[ Price : $8.95]

Consulting editor John Scharmann receives an unsatisfactory response from CVM about its continued approval of growth-promotant ant...

FDA Extends Review of Novartis Tekturna NDA

[ Price : $8.95]

FDA extends by up to three months its review of a Novartis NDA for its blood pressure drug Tekturna to allow additional data to be...

FDA Proposes to Expand Access to Investigational Drugs

[ Price : $8.95]

Federal Register Proposed rule: FDA proposes to amend its regulations to improve access to investigational drugs for patients with...

FDA Rule on Charging Patients for Investigational Drugs

[ Price : $8.95]

Federal Register Proposed rule: FDA proposes to amend its regulations by clarifying the circumstances in which charging for an inv...

Postmarket Surveillance Info Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDAs proposed collection of information on postmarket surveillance has been submited to the Office of Man...

LA District, SoCRA Plan Workshop on Trial Regs

[ Price : $8.95]

Federal Register Notice: FDAs LA District and the Society of Clinical Research Associates plan a public workshop 2/7-8 in San Dieg...